# Regular Use Tiotropium and Tolerance to Bronchoprotection in Mild Asthma

> **NCT05113615** · PHASE4 · COMPLETED · sponsor: **University of Saskatchewan** · enrollment: 12 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Tiotropium Bromide
- **DRUG:** Matching placebo

## Key facts

- **NCT ID:** NCT05113615
- **Lead sponsor:** University of Saskatchewan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-13
- **Primary completion:** 2022-05-06
- **Final completion:** 2022-05-06
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2022-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05113615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05113615, "Regular Use Tiotropium and Tolerance to Bronchoprotection in Mild Asthma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05113615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*